📖完整指南2026 更新🔬循证医学

Vyleesi (Bremelanotide) HSDD 指南 2026

完整指南与证据 (2026)

Vyleesi (Bremelanotide) 完整指南,这是一种经 FDA 批准用于治疗女性性欲低下障碍 (HSDD) 的多肽药物。

Dashboard
Your complete health overview in one place
🔥
14-day streak
Logged 18 of 18 scheduled shots
Next Shot Reminder
ACTIVE MEDICATIONS
VyleesiB12
VYLEESI
🔥 14
2
days away
Thursday · 7.5mg
Medication Supply
Vyleesi
6.2 / 10 mg · Vial
~42 days left · Mar 15
B12
4.4 / 5 ml · Vial
~88 days left · May 8
Retatrutide
1.2 / 5 mg · Vial
~6 days left · refill soon
Medication Levels
7 Days2 Weeks1 Month90 Days
CURRENT LEVEL
5.42mg
Mar 6
Today
ACTIVE MEDICATIONS
VyleesiRetatrutide
0mg2.7mg5.4mg
18
Total Injections
💉 All time
122/78
Average BP
🩺 mmHg
8.4
Avg Mood
😊 /10
Health Chart
1mAll
218.6lb
↓ 8.4 lb · 3.7%
WeightInjectionsBPMood
2282222162102277.5mg7.5mg4mg10mg218
Feb 6Feb 14Feb 22Mar 2Today
Photos
12 photos · 2w streak
Week 1
Week 7
Today
Scheduled Reminders
Weight
Due today
Mood
Done
Blood Pressure
Tomorrow
Body Measurements
In 3 days
Dashboard
Your complete health overview in one place
🔥
14-day streak
Logged 18 of 18 scheduled shots
Next Shot Reminder
ACTIVE MEDICATIONS
VyleesiB12
VYLEESI
🔥 14
2
days away
Thursday · 7.5mg
Medication Supply
Vyleesi
6.2 / 10 mg · Vial
~42 days left · Mar 15
B12
4.4 / 5 ml · Vial
~88 days left · May 8
Retatrutide
1.2 / 5 mg · Vial
~6 days left · refill soon
Medication Levels
7 Days2 Weeks1 Month90 Days
CURRENT LEVEL
5.42mg
Mar 6
Today
ACTIVE MEDICATIONS
VyleesiRetatrutide
0mg2.7mg5.4mg
18
Total Injections
💉 All time
122/78
Average BP
🩺 mmHg
8.4
Avg Mood
😊 /10
Health Chart
1mAll
218.6lb
↓ 8.4 lb · 3.7%
WeightInjectionsBPMood
2282222162102277.5mg7.5mg4mg10mg218
Feb 6Feb 14Feb 22Mar 2Today
Photos
12 photos · 2w streak
Week 1
Week 7
Today
Scheduled Reminders
Weight
Due today
Mood
Done
Blood Pressure
Tomorrow
Body Measurements
In 3 days
01BACKGROUND

FDA 批准的 HSDD 多肽药物

Vyleesi(通用名 Bremelanotide,原名 PT-141)是一种经 FDA 批准的注射用多肽,旨在治疗绝经前女性的性欲低下障碍 (HSDD)。

02DEEP DIVE

什么是 Vyleesi (Bremelanotide)?

Vyleesi(通用名 Bremelanotide,原名 PT-141)是一种经 FDA 批准的注射用多肽,旨在治疗绝经前女性的性欲低下障碍 (HSDD)。

与改变血流量的 PDE5 抑制剂(如伟哥)不同,Vyleesi 通过结合黑素皮质素受体在中枢神经系统起作用,激活与性唤起和性欲相关的神经通路。

03MECHANICS

核心生物机制

1
黑素皮质素受体(MC1R 和 MC4R)的非选择性激动剂
2
MC4R 结合直接调节性反应和唤起
3
作用于欲望阶段——恢复性欲,而不仅仅是生理机制
4
刺激黑素皮质素通路导致下游多巴胺释放
5
多巴胺是负责期待、奖励和欲望的主要神经递质
6
效果在注射后 45-60 分钟内逐渐显现
04DEEP DIVE

给药方案

皮下注射(SubQ)于腹部或大腿。

在预期活动前至少 45 分钟使用。

24 小时内不得超过一剂,每月最多 8 剂。

注意:约 40% 的患者会出现严重恶心。通常需要配合止吐药或缓慢滴定。切勿超过剂量限制——这会导致血压剧烈飙升。

05WHAT TO TRACK

副作用与安全性

01
🔬
Common Effects
Nausea (40% of patients — most common). Facial flushing and warmth. Headache. Injection site reactions
02
🔬
Important Warnings
Focal hyperpigmentation if used more than 8x/month. Blood pressure elevation at higher doses. Not for use in men (off-label PT-141 is different). Skin darkening of gums, face, or breasts possible
06WHAT TO TRACK

关键方案常见问题

01
🔬
Why does Vyleesi cause such bad nausea?
Because it activates melanocortin receptors everywhere, it triggers nausea centers in the brain. For many, nausea fades after a few uses, but for some it requires discontinuation.
02
🔬
Does Vyleesi work for men?
While exclusively FDA-approved for premenopausal women, the generic peptide (Bremelanotide/PT-141) is widely used in men for inducing spontaneous erections by bypassing nitric-oxide pathways.
03
Will it darken my skin?
Yes, focal hyperpigmentation was observed in trials if used more than 8 times a month, due to MC1R (tanning receptor) activation.
07FAQ

指南常见问题

Vyleesi (Bremelanotide) 完整指南,这是一种经 FDA 批准用于治疗女性性欲低下障碍 (HSDD) 的多肽药物。

可以。Shotlee 支持追踪 Vyleesi 的剂量、副作用和健康指标。该应用可免费使用。

Free · Always

在 Shotlee 中追踪您的 Vyleesi 方案

免费记录剂量、追踪副作用并监测健康指标,为您提供完整的方案管理。

📚References & sources

Start tracking